Aza Compounds/pharmacokinetics; Long QT Syndrome/chemically induced; Models, Biological; Phenethylamines/pharmacokinetics; Quinolines/pharmacokinetics; Sulfonamides/pharmacokinetics; Adult; Animals; Aza Compounds/toxicity; Azabicyclo Compounds/pharmacokinetics; Azabicyclo Compounds/toxicity; Benzimidazoles/pharmacokinetics; Benzimidazoles/toxicity; Carbamates/pharmacokinetics; Carbamates/toxicity; Clinical Trials, Phase I as Topic; Dogs; Double-Blind Method; Drug Evaluation, Preclinical/methods; Electrocardiography; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Phenethylamines/toxicity; Quinolines/toxicity; Randomized Controlled Trials as Topic; Retrospective Studies; Species Specificity; Sulfonamides/toxicity; Telemetry; Translational Research, Biomedical; Young Adult

Dofetilide; Dog; Methods; Moxifloxacin; PKPD; QT interval; Translation